VCP
CME icon

Verus Capital Partners’s CME Group CME Stock Holding History

Verus Capital Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33M Buy
7,905
+10
+0.1% +$2.97K 0.16% 95
2025
Q4 		$2.16M Buy
7,895
+873
+12% +$237K 0.14% 101
2025
Q3 		$1.9M Buy
7,022
+40
+0.6% +$10.9K 0.15% 95
2025
Q2 		$1.92M Sell
6,982
-1,043
-13% -$284K 0.17% 81
2025
Q1 		$2.13M Buy
8,025
+11
+0.1% +$2.71K 0.21% 68
2024
Q4 		$1.86M Buy
8,014
+261
+3% +$60K 0.18% 79
2024
Q3 		$1.71M Sell
7,753
-68
-0.9% -$14.1K 0.17% 85
2024
Q2 		$1.54M Sell
7,821
-110
-1% -$22.7K 0.16% 93
2024
Q1 		$1.71M Sell
7,931
-160
-2% -$33.6K 0.19% 79
2023
Q4 		$1.7M Buy
8,091
+115
+1% +$24.5K 0.21% 73
2023
Q3 		$1.6M Buy
7,976
+160
+2% +$31.8K 0.22% 71
2023
Q2 		$1.45M Sell
7,816
-35
-0.4% -$6.47K 0.21% 76
2023
Q1 		$1.5M Buy
7,851
+175
+2% +$31.6K 0.24% 71
2022
Q4 		$1.29M Buy
7,676
+140
+2% +$24.3K 0.24% 70
2022
Q3 		$1.33M Buy
7,536
+4,001
+113% +$791K 0.25% 62
2022
Q2 		$1.55M Sell
3,535
-4,016
-53% -$851K 0.3% 56
2022
Q1 		$1.59M Buy
+7,551
New +$1.77M 0.25% 69
2020
Q1 		$1.25M Buy
7,245
+67
+0.9% +$13.3K 0.39% 44
2019
Q4 		$1.44M Buy
+7,178
New +$1.47M 0.47% 37

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verus Capital Partners's CME Position: Q1 2026 in Review

Verus Capital Partners increased its CME Group (CME) stake by 0.13% in Q1 2026, buying an estimated $2.97K and bringing the position to 7,905 shares worth $2.33M. The position accounts for 0.16% of the portfolio, ranked #95.

Verus Capital Partners first reported a position in CME in Q4 2019 and has held it in 19 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Verus Capital Partners held 7,905 shares of CME Group worth $2.33M as of Q1 2026.
  • Verus Capital Partners bought 10 CME Group shares in Q1 2026, an estimated $2.97K.
  • CME Group made up 0.16% of Verus Capital Partners's portfolio in Q1 2026, its #95 holding.
  • Verus Capital Partners first reported a position in CME Group in Q4 2019 and has held it in 19 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.